The 10th Annual Immuno-Oncology Summit was held in Boston during October 12-14, 2022. Creative Biolabs, as an exhibitor, successfully showcased at the 10th Annual Immuno-Oncology Summit at booth #9 and has attracted many attendees during its exhibition. Throughout the show, our team of professionals answered questions regarding drug development in the field of immuno-oncology for visiting guests and scientists.
The Immuno-Oncology Summit has been designed to support the coordinated effort by industry players to bring commercial immunotherapies and immunotherapy combinations through clinical development into the market. This weeklong, nine-meeting set covered topics ranging from early discovery through clinical development as well as emerging areas, such as oncolytic virotherapy. Overall, this event provided a focused look at how researchers are applying new science and technologies in the development of next-generation effective and safe immunotherapies.
To point out, one of the conference programs of the 10th Annual Immuno-Oncology Summit, Bispecific Antibodies for Cancer Immunotherapy, covered topics of bispecific antibody development, including:
- Improving the Therapeutic Index of T-Cell Engagers
- Agonist Bispecifics
- Targeting and Delivery Strategies
- Multispecific Biotherapeutics
The 10th Annual Immuno-Oncology Summit has drawn its curtain. Thank you for your enthusiastic attention to our booth and we look forward to seeing you at the next Immuno-Oncology Summit.
Creative Biolabs is proud to exhibit and participate in industry conferences where our scientists showcase innovative drug discovery solutions. Whether diving into scientific research, biopharmaceutical discovery and development, or industrial manufacturing, we strongly encourage you to come and meet us at our upcoming conferences!